Document:

Exhibit 10.06

 

BIG
Token, inc.

2629 Townsgate Rd., Suite 215

Westlake Village, CA 91362

 

December
___, 2020

 

Lou
Kerner

«EmployeeAddress1»

«EmployeeAddress2»

 

	 	Re:	EMPLOYMENT
    AGREEMENT

 

Dear
Mr. Kerner:

 

On
behalf of BIG Token, Inc., a Delaware corporation (“BIG Token”), I am pleased to offer you the position of
Chief Executive Officer of BIG Token and the public company with which the Company shall merge (“Merger”) into
(anticipated to be Force Protection Video Equipment Corp.) (“PubCo” and together with BIG Token, the “Company”).
Your employment by the Company shall be governed by the following terms and conditions (this “Agreement”):

 

1.
Duties and Scope of Employment.

 

(a)
Position. For the term of your employment under this Agreement (your “Employment”), the Company
agrees to employ you in the position of Chief Executive Officer or in such other position as the Company subsequently may assign
to you, which shall be of equal or more prominent position as the position of the Chief Executive Officer. You will report to
the Company’s Board of Directors (“Board”). You will perform the duties and have the responsibilities and authority
customarily performed and held by an employee in your position or as otherwise may be assigned or delegated to you by the Company’s
Board.

 

(b)
Obligations to the Company. During your Employment, you shall devote majority of your full business efforts and
time to the Company. During your Employment, without the prior written approval of the Board, you shall not render services in
any capacity to any other person or entity and shall not act as a sole proprietor or partner of any other person or entity or
own more than five percent of the stock of any other corporation, except as set forth on Exhibit A attached hereto. The
Company hereby acknowledges and agrees that all such activities conducted by you as of the Effective Date (including all boards
of directors on which you serve as of the Effective Date) which are listed on Exhibit A to this Agreement, do not interfere with
your performance of this Agreement and do not compete with the business of the Company. Notwithstanding the foregoing, you may
serve on corporate, civic or charitable boards or committees, deliver lectures, fulfill speaking engagements, teach at educational
institutions, or manage personal investments without such advance written consent, provided that such activities do not individually
or in the aggregate interfere with the performance of your duties under this Agreement. You shall comply with the Company’s
policies and rules, as they may be in effect from time to time during your Employment.

 

    	 

    	 

    

 

(c)
No Conflicting Obligations. You represent and warrant to the Company that you are under no obligations or commitments,
whether contractual or otherwise, that are inconsistent with your obligations under this Agreement. In connection with your Employment,
you shall not use or disclose any trade secrets or other proprietary information or intellectual property in which you or any
other person has any right, title or interest and your Employment will not infringe or violate the rights of any other person.
You represent and warrant to the Company that you have returned all property and confidential information belonging to any prior
employer.

 

(d)
Commencement Date. You shall commence full-time Employment immediately upon satisfaction of the conditions contained
in Section 9 hereof (such date on which Employment shall begin is referred to herein as the “Effective Date”).

 

2.
Cash and Incentive Compensation.

 

(a)
Salary. The Company shall pay you as compensation for your services an initial base salary at a gross annual rate
of $175,000. Such salary shall be payable in accordance with the Company’s standard payroll procedures. The annual compensation
specified in this subsection (a), together with any modifications in such compensation that the Company may make from time to
time, is referred to in this Agreement as “Base Salary.”

 

(b)
Incentive Bonuses. You will be eligible to be considered for an annual incentive bonus each calendar year during
the term of your employment under this Agreement based upon the achievement of certain objective or subjective criteria established
by the Board or any Compensation Committee of the Board. The target amount for any such annual incentive bonus will be
up to 100% of your Base Salary (“Target Bonus”). The determinations of the Board in good faith with respect
to such bonus shall be final and binding. You shall not earn an incentive bonus unless you are employed by the Company on the
date when such bonus is payable, unless you are terminated without Cause or you terminate this Agreement for Good Reason. For
purposes of determining your bonus, during December of each year, the Board or any Compensation Committee of the Board will determine
a performance base line amount (“Performance Base Line”). If you achieve 80% of the Performance Base Line for
a given year, you will receive 50% of your Target Bonus for such year. If you achieve your Performance Base Line for a given year,
you will receive 100% of your Target Bonus for such year. Your Performance Base Line for you initial year of Employment which
commences on January 1, 2021 and ends of December 31, 2021 is $5.5 million of Gross Profit, as calculated in accordance with generally
accepted accounting principles in the United States (“GAAP”). Notwithstanding the foregoing, the Board or any
Compensation Committee of the Board may grant you a greater bonus amount at their sole and absolute discretion.

 

    	2

    	 

    

 

(c)
Stock Options. Subject to the approval of the Board, upon the Company completing an offering of its securities resulting
in gross proceeds of at least $3,000,000 (“Financing”), the Company shall grant you a stock option to purchase five
(5) percent of the Company’s issued and outstanding Common Stock, post Financing on a fully diluted basis (the “Option”).
The Option shall be granted as soon as reasonably practicable after the completion of the Financing. The exercise price per Option
will be: (i) 33.33% will be granted at an imputed Market Capitalization of $15 million, (ii) 33.33% will be granted at an imputed
Market Capitalization of $17.5 million, and (iii) the remaining Options will have an exercise price equity to an imputed Market
Capitalization of $20 million. The term of the Option shall be 10 years, subject to earlier expiration in the event of the termination
of your services to the Company. The Option shall vest and become exercisable as follows: (x) 33.3% on the one-year anniversary
of the Effective Date (the “Initial Vesting Date”), and (y) the remaining options will vest in equal installments
quarterly over a period of two years from the Initial Vesting Date, with the first quarterly installment to vest on the first
quarterly anniversary of the Initial Vesting Date. The Option will be a nonqualified stock option and shall be subject to the
other terms and conditions set forth in the Company’s Equity Compensation Plan to be adopted by the Company in connection
with the Merger in a standard and customary form (the “Stock Plan”) and in the Company’s standard form
of Stock Option Agreement (the “Stock Agreement”). The Company agrees to establish, or cause the establishment
of the Stock Plan promptly, but in no event later than ten days, after the consummation of the Merger. Market Capitalization is
defined as: (a) the Company’s issued and outstanding Common Stock plus any convertible securities on an as converted basis,
divided by (b) the closing price of the Company’s Common Stock on its primary trading market. Any terms not defined herein
will have the meaning ascribed to it in the Stock Plan. As permitted by law, on or before the Initial Vesting Date, the Company
shall use its commercially reasonable best efforts to file a Registration Statement on Form S-8 with the U.S. Securities and Exchange
Commission (the “SEC”) to allow you (and if permitted by the Company, other senior executives) to (x) sell
a number of shares of Common Stock the vested Options sufficient to cover your employment tax obligation arising in connection
with the exercise of your Option in the open market pursuant to such Form S-8, and (y) sell the remaining vested Options if and
when you determine during any open trading window.

 

(d)
Acceleration Benefit. Provided the Company has either: (i) not requested for your employment to continue immediately
after a Triggering Event or (ii) has requested for your employment to continue immediately after a Triggering Event on terms significantly
similar to your employment terms, including Base Salary, immediately prior to the Trigger Event, and you have not rejected such
request, then, effective immediately before the consummation of a Triggering Event, any and all of your outstanding unvested
equity awards of the Company shall accelerate and become fully exercisable, and any repurchase right of the Company as a result
of the Triggering Event applicable to such equity award shall lapse as to all of the number of shares of capital stock of the
Company underlying such equity awards In addition, the acceleration of vesting and lapse of repurchase rights provided for in
the previous sentence shall occur immediately prior to the effective date of termination of your Continuous Service Status as
provided in Section 7. In order to be eligible for such acceleration of vesting benefit, you must execute the Company’s
standard reasonable form of mutual release of all claims agreement.

 

    	3

    	 

    

 

(e)
Benefits. Except as otherwise agreed to by you or elected by you in any applicable voluntary election materials,
you shall be eligible to participate in and shall receive all or comparable benefits under all welfare plans, pension plans, fringe
benefit plans, other benefit plans, and all other arrangements, plans, policies, and programs in each case (w) that the Company
makes available generally to the senior executives of the Company or of any other subsidiary or affiliate of the Company, (x)
that are sponsored or maintained by the Company or any subsidiary or affiliate of the Company or to which the Company or any subsidiary
or affiliate of the Company contributes, (y) on a basis no less favorable than the basis as such arrangements, plans, policies,
and programs are applicable or made available to the other senior executives of the Company or any subsidiary or affiliate of
the Company, and (z) whether now existing or established hereafter, including (a) all accidental death, business travel insurance,
death benefits, dental, disability (including short-term disability and long-term disability), flexible spending accounts, health,
hospitalization, life insurance, long term care, medical, prescription drug, salary continuation, sickness, surgical, vacation,
vision, welfare, wellness, and similar arrangements, plans, policies, or programs, and (b) all change in control, deferred compensation,
deferred stock unit, executive compensation, incentive (or other) bonus (whether short-term, long-term, or otherwise), other equity-based
compensation, pension, profit sharing, restricted stock, restricted stock unit, retention, retirement, savings, stock appreciation
right, stock option, stock purchase, supplemental retirement, and similar arrangements, plans, policies, and programs (collectively,
the “Benefit Plans”). The Company agrees that your eligible dependents shall have the right to participate
in all Benefit Plans as permitted in accordance with the applicable terms of the respective Benefit Plan and that the Company’s
medical and hospital plan shall provide coverage for your eligible dependents.

 

(i)
Definitions:

 

A.
“Continuous Service Status” means the absence of any interruption or termination of service as an employee
or consultant of the Company. Continuous Service Status as an employee or consultant shall not be considered interrupted or terminated
in the case of: (i) Company approved sick leave; (ii) military leave; (iii) any other bona fide leave of absence approved by the
Board, provided that such leave is for a period of not more than ninety (90) days, unless reemployment upon the expiration of
such leave is guaranteed by contract or statute, or unless provided otherwise pursuant to a written Company policy. Also, Continuous
Service Status as an employee or consultant shall not be considered interrupted or terminated in the case of a transfer between
locations of the Company or between the Company, its parents, subsidiaries or affiliates, or their respective successors, or a
change in status from an employee to a consultant or from a consultant to an employee.

 

B.
“Involuntary Termination” means (unless another definition is provided in the applicable equity grant documents,
employment agreement or other applicable written agreement) the termination of your Continuous Service Status (i) other than for
death or Permanent Disability (as defined below) or for Cause by the Company or a subsidiary, parent, affiliate or successor thereto,
as appropriate, or (ii) for Good Reason.

 

C.
“Triggering Event” means:

 

(x)
a sale, transfer or disposition of all or substantially all of the Company’s assets other than to (A) a corporation or other
entity of which at least a majority of its combined voting power is owned directly or indirectly by the Company, (B) a corporation
or other entity owned directly or indirectly by the holders of capital stock of the Company in substantially the same proportions
as their ownership of Common Stock, or (C) an Excluded Entity (as defined in subsection (ii) below); or

 

    	4

    	 

    

 

(y)
any merger, consolidation or other business combination transaction of the Company with or into another corporation, entity or
person, other than a transaction with or into another corporation, entity or person in which the holders of at least a majority
of the shares of voting capital stock of the Company outstanding immediately prior to such transaction continue to hold (either
by such shares remaining outstanding in the continuing entity or by their being converted into shares of voting capital stock
of the surviving entity) a majority of the total voting power represented by the shares of voting capital stock of the Company
(or the surviving entity) outstanding immediately after such transaction (an “Excluded Entity”).

 

(z)
Notwithstanding anything stated herein, a transaction shall not constitute a “Triggering Event” if: (i) its sole purpose
is to change the state of the Company’s incorporation, or to create a holding company that will be owned in substantially
the same proportions by the persons who hold the Company’s securities immediately before such transaction or (ii) results
from a decrease in ownership percentage of SRAX, Inc. as a result of the Company issuing securities other than in connection with
the events described in Section 2(i)(C)(x) and (y). For clarity, the term “Triggering Event” as defined herein shall
not include stock sale transactions whether by the Company or by the holders of capital stock other than in connection with the
events described in Section 2(i)(C)(x) and (y).

 

3.
Vacation/PTO and Employee Benefits. During your Employment, you shall be eligible to accrue up to 14 days of paid
vacation / paid time off, pro-rated for the remainder of this calendar year, in accordance with the Company’s vacation /
paid time off policy, as it may be amended from time to time. Any unused vacation/paid time off days shall be rolled over to the
next year (not to exceed 10 days). During your Employment, you shall be eligible to participate in the employee benefit plans
maintained by the Company and generally available to similarly situated employees of the Company, subject in each case to the
generally applicable terms and conditions of the plan in question and to the determinations of any person or committee administering
such plan.

 

4.
Business Expenses. The Company will reimburse you for your necessary and reasonable business expenses incurred in
connection with your duties hereunder upon presentation of an itemized account and appropriate supporting documentation, all in
accordance with the Company’s generally applicable policies.

 

5.
Clawback Provisions. If the Company is required to adopt a clawback policy pursuant to any applicable law, government
regulation or stock exchange listing requirement, you agree to enter into the same clawback arrangement as applicable to all senior
management of the Company.

 

6.
Termination.

 

(a)
Employment at Will. Your Employment shall be “at will,” meaning that either you or the Company shall
be entitled to terminate your Employment at any time and for any reason, with or without Cause or Good Reason. Any contrary representations
that may have been made to you shall be superseded by this Agreement. This Agreement shall constitute the full and complete agreement
between you and the Company on the “at-will” nature of your Employment, which may only be changed in an express written
agreement signed by you and a duly authorized officer of the Company.

 

    	5

    	 

    

 

(b)
Rights Upon Termination. Except as expressly provided in Section 6, upon the termination of your Employment, you
shall only be entitled to the compensation and benefits earned and the reimbursements described in this Agreement for the period
preceding the effective date of the termination.

 

7.
Termination Benefits.

 

(a)
General Release. Any other provision of this Agreement notwithstanding, Section 2(d) and subsections (b) and (c)
below shall not apply unless and until (i) you have executed (and do not revoke) a full and complete mutual general release of
all claims in a reasonable form provided by the Company and (ii) you have returned all Company property.

 

(b)
Severance Pay. If, during the term of this Agreement, the Company terminates your Employment for any reason other
than Cause, death or Permanent Disability or you terminate this Agreement for Good Reason, then, in addition to the amounts payable
in accordance with Section 6(b), (i) the Company shall pay you severance pay at a rate equal to your Base Salary in effect at
the time of termination of your Employment for a period of twelve (12) months following the termination of your Employment (the
“Continuation Period”), and (ii) any and all of your outstanding unvested equity awards of the Company shall
accelerate and become fully exercisable, and any repurchase right of the Company as a result of the Triggering Event applicable
to such equity award shall lapse as to all of the number of shares of capital stock of the Company underlying such equity awards.
Such severance pay shall be paid in accordance with the Company’s standard payroll procedures on the Company’s payroll
dates and shall be subject to all applicable withholdings; provided that, if the Company’s stock becomes publicly traded
on an established securities market, such severance pay shall be paid in a single lump-sum cash payment on the six (6) month anniversary
of the employment termination date to the extent required by Code section 409A.

 

(c)
Health Insurance. If subsection (b) above applies, and if you elect to continue and pay your health insurance coverage
under the Consolidated Omnibus Budget Reconciliation Act (“COBRA”) following the termination of your Employment,
then the Company shall pay your monthly premium under COBRA until the earliest of (i) the end of the Continuation Period, (ii)
the expiration of your continuation coverage under COBRA or (iii) the date when you receive substantially equivalent health insurance
coverage in connection with new employment or self-employment.

 

(d)
Definition of “Cause.” For all purposes under this Agreement, “Cause” shall mean:

 

(i)
Any breach by you of this Agreement, the Confidential Information and Invention Assignment Agreement between you and the Company,
or any other written agreement between you and the Company, in any case which is not cured by you within thirty (30) days after
the Company provides to you written notice thereof with reasonable detail of the nature of such breach;

 

    	6

    	 

    

 

(ii)
Any failure by you to comply with the Company’s written policies or rules, as they may be in effect from time to time during
your Employment, that are generally applicable to all employees or officers of the Company and that results or which could be
reasonably expected to result in a material negative effect on the business of the Company, but solely to the extent such policies
were made available to you prior to such failure;

 

(iii)
Your repeated and continuous failure to follow reasonable and lawful instructions from the Company or the Board of the Company
and your failure to cure such condition after receiving 20 days advance written notice. For the purposes of this Section “repeated”
means more than two (2) times;

 

(iv)
A plea of “guilty” or “no contest” to any charge of a felony requiring intent under the laws of the United
States or any State thereof, or your conviction of a felony requiring intent under the laws of the United States or any State
thereof, after the exhaustion of all possible appeals, in each case excluding any Limited Vicarious Liability (as hereinafter
defined). For the purposes hereof, “Limited Vicarious Liability” means any liability that (x) is based on acts
or omissions of the Company for which you are responsible solely as a result of his offices with the Company, where you were not
directly involved in such acts or omissions and either had no prior knowledge of such intended acts or omissions or upon obtaining
any such knowledge promptly acted reasonably and in good faith to attempt to prevent the acts or omissions causing such liability,
or (y) you did not have a reasonable basis to believe that any applicable law was being violated by such acts or omissions; or

 

(v)
Your misappropriation of funds or property of the Company;

 

(vi)
Any gross or willful misconduct by you which is not cured by you within thirty (30) days prior written notice by the Company to
you. For the purposes hereof: (i) any act or omission (including any refusal or violation) by you is “willful” only
if the same is not in good faith and is without the reasonable belief by you that such act or omission is in the best interests
of the Company; and (ii) any act or omission by you based upon any authority granted pursuant to a resolution duly adopted by
the Board or based upon the advice of counsel for the Company in each case is presumed to be in good faith and in the best interests
of the Company. For avoidance of doubt, “Cause” does not include (i) differences of opinion with respect to strategy
or implementation of business plans, (ii) the success or lack of success of any such strategy or implementation, or (iii) any
failure to achieve any performance or economic objectives, whether relating to you, the Company, or otherwise.

 

Notwithstanding
anything to the contrary contained herein, no cessation of your employment with the Company shall be deemed to be for Cause unless,
on or before the six month anniversary of the first date the Board has knowledge of the act or omission alleged to constitute
Cause, or if later, the last day of the applicable Cause cure period, the Company delivers to you a copy of a resolution duly
adopted by the affirmative vote of a majority of the Board (excluding you if you are a member thereof) at a meeting called and
held for such purpose (i) finding that, in the good faith opinion of the Board, your conduct constitutes Cause hereunder, and
(ii) authorizing the termination of your employment for Cause.

 

    	7

    	 

    

 

(e)
Definition of “Good Reason.” For all purposes under this Agreement, “Good Reason”
shall mean:

 

(i)
a reduction in your then-current base salary or then-current Target Bonus, or the Company’s failure to pay you any other
material amounts owed to you within thirty (30) days after the date such payment was due to you under this Agreement; provided,
that Good Reason shall not be deemed to exist if the Company reduces your then-current base salary or then-current Target Bonus
at the same percentage as applied to all other senior executives of the Company;

 

(ii)
the assignment to you of any authorities, duties, functions, offices, positions, or responsibilities, that materially impair your
ability to function as the CEO of the Company (or any other position in which you are then serving) or the assignment to you of
any duties that are materially inconsistent with any of the provisions of Section 1(a);

 

(iii)
the Company failing to comply with Section 11(g); or

 

(iv)
or any other material breach of this Agreement by the Company.

 

(f)
Definition of “Permanent Disability.” For all purposes under this Agreement, “Permanent Disability”
shall mean your inability to perform the essential functions of your position with or without reasonable accommodation for a period
of 120 consecutive days because of your physical or mental impairment.

 

8.
Non-Solicitation. During the period commencing on the date of this Agreement and continuing until the date when
your Employment terminated for any reason, you shall not directly or indirectly, personally or through others, solicit or attempt
to solicit (on your own behalf or on behalf of any other person or entity) either (i) any employee or any consultant of the Company
or any of the Company’s affiliates or (ii) the business of any customer of the Company or any of the Company’s affiliates
on whom you called or with whom you became acquainted during your Employment.

 

9.
Pre-Employment Conditions.

 

(a)
Confidentiality Agreement. Your acceptance of this offer and commencement of employment with the Company is contingent
upon the execution, and delivery to an officer of the Company, of the Company’s Confidential Information and Invention Assignment
Agreement, a copy of which is enclosed for your review and execution (the “Confidentiality Agreement”), prior
to or on your Start Date.

 

(b)
Right to Work. For purposes of federal immigration law, you will be required to provide to the Company documentary
evidence of your identity and eligibility for employment in the United States. Such documentation must be provided to us within
three (3) business days of your Start Date, or our employment relationship with you may be terminated.

 

    	8

    	 

    

 

(c)
Verification of Information. This offer of employment is also contingent upon the successful verification of the
information you provided to the Company during your application process, as well as a general background check performed by the
Company to confirm your suitability for employment. By accepting this offer of employment, you warrant that all information provided
by you is true and correct to the best of your knowledge, you agree to execute any and all documentation necessary for the Company
to conduct a background check and you expressly release the Company from any claim or cause of action arising out of the Company’s
verification of such information.

 

(d)
Financing. This offer of employment and your commencement of employment with the Company is contingent on the Company
securing financing resulting in gross proceeds of $3,000,000 on or before February 1, 2021.

 

(e)
Merger. This offer of employment and your commencement of employment with the Company is contingent on closing of
the Merger. For the avoidance of doubt, this Agreement shall automatically become effective upon the satisfaction of the conditions
in this Section 9.

 

10.
Successors.

 

(a)
Company’s Successors. This Agreement shall be binding upon any successor (whether direct or indirect and whether
by purchase, lease, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company’s business
and/or assets. For all purposes under this Agreement, the term “Company” shall include any successor to the
Company’s business or assets that becomes bound by this Agreement.

 

(b)
Your Successors. This Agreement and all of your rights hereunder shall inure to the benefit of, and be enforceable
by, your personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.

 

    	9

    	 

    

 

11.
Miscellaneous Provisions.

 

(a) Indemnification.
The Company shall indemnify you and hold harmless to the maximum extent permitted by applicable law from and against any and
all expenses (including, without limitation, reasonable attorneys’ fees, fees of experts, witness fees, fees of other
professional advisors, other disbursements incurred in connection with prosecuting, defending, preparing to prosecute or
defend, investigating, appealing, or participating in a Proceeding (as hereinafter defined), bonds, all interest,
assessments, and other charges paid or payable in connection with or in respect of the foregoing, and any federal, state,
local, or foreign taxes imposed on you as a result of the actual or deemed receipt of any payments pursuant to this Section
11 (all of the foregoing, collectively, “Expenses”), demands, claims, damages, judgments, penalties,
fines, settlements, and all other liabilities incurred or paid by you, or on your behalf, in connection with the
investigation, defense, prosecution, settlement or appeal(s) of any threatened, pending or completed action, suit,
proceeding, alternative dispute resolution mechanism, investigation, inquiry, or hearing (including any administrative
hearing), whether civil, criminal, administrative or investigative and to which you were or are a party or other participant
or is threatened to be made a party or other participant (a “Proceeding”), or any claim, issue, or matter
therein (including any Proceeding brought by or in the right of the Company or any of its subsidiaries or affiliates), by
reason of or arising from the fact that you are or were a director, officer, employee, agent, or fiduciary of the Company or
of any subsidiary or affiliate of the Company or, at the request of the Company, of any other corporation, partnership, joint
venture, trust, employee benefit plan, or other enterprise in connection with your employment by the Company or at the
direction of the Company or any of its affiliates, or by reason of or arising from anything done or not done by you in any
such capacity or capacities, (including any Proceeding, or any claim, issue, or matter therein, by reason of or arising from:
any actual or alleged breach by you of your fiduciary duty as a director or officer of the Company or of any subsidiary or
affiliate of the Company; the registration, purchase, sale, or ownership of any securities of the Company, the Merger or any
fiduciary obligation owed with respect thereto; or any misstatement or omission of material fact by the Company in violation
of any duty of disclosure imposed on the Company by any federal, state, or foreign securities or common laws), provided that
you acted in good faith and in a manner that was not grossly negligent and you reasonably believed to be in or not opposed to
the best interests of the Company or such other subsidiary or affiliate of the Company, and, with respect to any criminal
Proceeding, had no reasonable cause to believe your conduct was unlawful. The Company also shall pay any and all Expenses
incurred by you as a result of you being called as a witness in connection with any matter involving the Company, any other
any subsidiary or affiliate of the Company, or any of its or their respective officers or directors. The Company shall pay
any Expenses, judgments, penalties, fines, settlements, and other liabilities incurred by you in investigating, defending,
settling or appealing any Proceeding described in this Section in advance of the final disposition of such Proceeding,
as such Expenses, judgments, penalties, fines, settlements, and other liabilities come due. The Company shall promptly pay
the amount of such Expenses, judgments, penalties, fines, settlements, and other liabilities to you, but, in respect of
advances of Expenses, in no event later than ten (10) days following your delivery to the Company of a written request for an
advance pursuant hereto, together with a reasonable accounting of such Expenses, and in respect of all other indemnification
payments, in no event later than thirty (30) days following your delivery to Company of a written request therefor, together
with such reasonable accounting or other applicable supporting information. The Company shall make the advances contemplated
by this Section regardless of your financial ability to make repayment, and regardless whether indemnification of you
by the Company will ultimately be required. Any advances and undertakings to repay pursuant to this Section shall be
unsecured and interest-free. Your rights pursuant to this Section shall be in addition to any other rights you may now
or hereafter have under the Company’s certificate of incorporation or bylaws (as now or hereafter in effect), any
agreement, any vote of stockholders or directors, applicable law, or otherwise. To the extent that a change in applicable law
(whether by statute, judicial decision, or otherwise) permits greater indemnification that would be afforded currently under
the Company’s certificate of incorporation or bylaws, applicable law, any other agreement, or this Section, it
is the intent of the Parties that Executive enjoy by this Section the greater benefits so afforded by such change.
Notwithstanding the foregoing, the Company will not be obligated to pay or reimburse any Expenses in connection with any
Proceedings from a breach of any of your pre-existing obligation as a result of your employment with the Company.

 

    	10

    	 

    

 

(b)
Insurance. You shall also be covered under a directors and officers liability insurance policy paid for by the Company
to the extent that the Company maintains such a liability insurance policy now or in the future. The Company represents and warrants
that SRAX, Inc. currently maintains such insurance that covers the Company, the post-Merger company (including the public company
into which the Company shall merge with and into as a result of the Merger) and their respective officers and directors (collectively,
the “Covered Persons”). If any time that SRAX Policy no longer covers the Covered Persons. The Company agrees that
(i) from such date and during the remaining portion of your employment period the Company, the Company will maintain in full force
and effect directors’ and officers’ liability insurance that has a liability limit of not less than Five Million Dollars
($5,000,000); (ii) in such insurance policy or policies maintained by the Company, you shall be named as an insured in such a
manner as to provide the same rights and benefits as are accorded to the most favorably insured of the Company’s officers
or directors, and (iii) such policy or policies shall include a “tail” for coverage for claims made within a minimum
of three (3) years following the end of your employment period.

 

(c)
Notice. Notices and all other communications contemplated by this Agreement shall be in writing and shall be deemed
to have been duly given when personally delivered or when mailed by U.S. registered or certified mail, return receipt requested
and postage prepaid. In your case, mailed notices shall be addressed to you at the home address that you most recently communicated
to the Company in writing, with a copy (which shall not constitute notice) to Jonathan Shechter, Esq., at js@foleyshechter.com.
In the case of the Company, mailed notices shall be addressed to its corporate headquarters, and all notices shall be directed
to the attention of its Secretary.

 

(d)
Modifications and Waivers. No provision of this Agreement shall be modified, waived or discharged unless the modification,
waiver or discharge is agreed to in writing and signed by you and by an authorized officer of the Company (other than you). No
waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party
shall be considered a waiver of any other condition or provision or of the same condition or provision at another time.

 

(e)
Whole Agreement. No other agreements, representations or understandings (whether oral or written and whether express
or implied) which are not expressly set forth in this Agreement have been made or entered into by either party with respect to
the subject matter hereof. This Agreement and the Confidentiality Agreement contain the entire understanding of the parties with
respect to the subject matter hereof.

 

(f)
Withholding Taxes. All payments made under this Agreement shall be subject to reduction to reflect taxes or other
charges required to be withheld by law.

 

(g)
Choice of Law and Severability. This Agreement shall be interpreted in accordance with the laws of the State of
California without giving effect to provisions governing the choice of law. If any provision of this Agreement becomes or is deemed
invalid, illegal or unenforceable in any applicable jurisdiction by reason of the scope, extent or duration of its coverage, then
such provision shall be deemed amended to the minimum extent necessary to conform to applicable law so as to be valid and enforceable
or, if such provision cannot be so amended without materially altering the intention of the parties, then such provision shall
be stricken and the remainder of this Agreement shall continue in full force and effect. If any provision of this Agreement is
rendered illegal by any present or future statute, law, ordinance or regulation (collectively, the “Law”) then
that provision shall be curtailed or limited only to the minimum extent necessary to bring the provision into compliance with
the Law. All the other terms and provisions of this Agreement shall continue in full force and effect without impairment or limitation.

 

    	11

    	 

    

 

(h)
No Assignment. This Agreement and each party’s rights and obligations hereunder are personal to such party
and may not be transferred or assigned by such party at any time; provided, that the Company may assign its rights and obligations
under this Agreement to any entity that assumes the Company’s obligations hereunder in connection with any sale or transfer
of all or substantial all of the Company’s assets to such entity.

 

(i)
Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same instrument.

 

(j)
Financing. You agree to assist the Company with its efforts to secure financing for the Company, through the sale
of its securities or otherwise, resulting in gross proceeds of approximately $3,000,000.

 

[Signature
Page Follows]

 

    	12

    	 

    

 

We
are all delighted to be able to extend you this offer and look forward to working with you. To indicate your acceptance of the
Company’s offer, please sign and date this letter in the space provided below and return it to me, along with a signed and
dated original copy of the Confidentiality Agreement, on or before «ReplyDate». The Company requests that you begin
work in this new position on or before «StartDate». Please indicate the date (either on or before the aforementioned
date) on which you expect to begin work in the space provided below (the “Start Date”).

 

	 	 	Very
    truly yours,
	 	 	 	 
	 	 	BIG
    tOKEN, inc.
	 	 	 	 
	 	 	By:	 
	 	 	 	(Signature)
	 	 	 	 
	 	 	Name:	 
	 	 	 	 
	 	 	Title:	 

 

	ACCEPTED
    AND AGREED:	 	 
	 	 	 
	lou
    kerner	 	 
	 	 	 
	 	 	 
	(Signature)	 	 
	 	 	 
	 	 	 
	Date	 	 

 

	Anticipated
    Start Date: 	 	 
	 	 	 
	Attachment
    A: Confidential Information and Invention Assignment Agreement

 

    	13

    	 

    

 

Exhibit
A

 

Outside
Activities, Investments and Board Positions

 

1.
CryptoOracle LLC - spinning out assets to shareholders, monetizing CryptoMondays, a Meetup group active in more than a dozen cities
around the world

 

2.
Blockchain Coinvestors Syndicate on AngelList - with over 150LPs, the syndicate sources investments in blockchain/crypto projects
and makes them available for our LPs

 

3.
SWAG - a personal token project in development

 

4.
Advisor

 

	 	1.	SilverCastle
    - an Israeli digital asset manager
	 	 	 
	 	2.	TNS
    Total Network Services (BoD) - cloud infrastructure, domain names, blockchain technology
	 	 	 
	 	3.	Vesto
    - white label platform for banks to offer cryptocurrency related services
	 	 	 
	 	4.	Quantum
    Economics - crypto analysis, advisory, and money management
	 	 	 
	 	5.	Blockchain
    Coinvestors - a crypto- fund-of-funds
	 	 	 
	 	6.	Detomena
    - a blockchain data company

 

    	 

    	 

    

 

ATTACHMENT
A

 

CONFIDENTIAL
INFORMATION AND

INVENTION ASSIGNMENT AGREEMENT

 

(See
Attached)

 

    	-2-Exhibit 10.07

 

FORCE
PROTECTION VIDEO EQUIPMENT CORPORATION

 

CONFIDENTIAL
INFORMATION AND

INVENTION ASSIGNMENT AGREEMENT

 

Candidate
Name:

 

Effective
Date:

 

As
a condition of my becoming employed (or my employment being continued) by Force Protection Video Equipment Corporation, a Florida
corporation, or any of its current or future subsidiaries, affiliates, successors or assigns (collectively, the “Company”),
and in consideration of my employment with the Company and my receipt of the compensation now and hereafter paid to me by the
Company, I agree to the following:

 

1.
Relationship. This Agreement will
apply to my employment relationship with the Company. If that relationship ends and the Company, within a year thereafter, either
re-employs me or engages me as a consultant, I agree that this Agreement will also apply to such later employment or consulting
relationship, unless the Company and I otherwise agree in writing. Any such employment or consulting relationship between the
Company and me, whether commenced prior to, upon or after the date of this Agreement, is referred to herein as the “Relationship.”

 

2.
Duties. I will perform for the
Company such duties as may be designated by the Company from time to time or that are otherwise within the scope of the Relationship
and not contrary to instructions from the Company. During the Relationship, I will devote my entire best business efforts to the
interests of the Company and will not engage in other employment or in any activities detrimental to the best interests of the
Company without the prior written consent of the Company.

 

3.
Confidential Information.

 

(a)
Protection of Information. I agree, at all times during the term of the Relationship and thereafter, to hold in
strictest confidence, and not to use, except for the benefit of the Company to the extent necessary to perform my obligations
to the Company under the Relationship, and not to disclose to any person, firm, corporation or other entity, without written authorization
from the Company in each instance, any Confidential Information (as defined below) that I obtain, access or create during the
term of the Relationship, whether or not during working hours, until such Confidential Information becomes publicly and widely
known and made generally available through no wrongful act of mine or of others who were under confidentiality obligations as
to the item or items involved. I further agree not to make copies of such Confidential Information except as authorized by the
Company.

 

(b)
Confidential Information. I understand that “Confidential Information” means information and
physical material not generally known or available outside the Company and information and physical material entrusted to the
Company in confidence by third parties. Confidential Information includes, without limitation: (i) Company Inventions (as defined
below); (ii) technical data, trade secrets, know-how, research, product or service ideas or plans, software codes and designs,
developments, inventions, laboratory notebooks, processes, formulas, techniques, biological materials, mask works, engineering
designs and drawings, hardware configuration information, lists of, or information relating to, suppliers and customers (including,
but not limited to, customers of the Company on whom I called or with whom I became acquainted during the Relationship), price
lists, pricing methodologies, cost data, market share data, marketing plans, licenses, contract information, business plans, financial
forecasts, historical financial data, budgets or other business information disclosed to me by the Company either directly or
indirectly, whether in writing, electronically, orally, or by observation.

 

    	-1-

    	 

    

  

(c)
Third Party Information. My agreements in this Section 3 are intended to be for the benefit of the Company and any
third party that has entrusted information or physical material to the Company in confidence.

 

(d)
Other Rights. This Agreement is intended to supplement, and not to supersede, any rights the Company may have in
law or equity with respect to the protection of trade secrets or confidential or proprietary information.

 

4.
Ownership of Inventions.

 

(a)
Inventions Retained and Licensed. I have attached hereto, as Exhibit A, a complete list describing with particularity
all Inventions (as defined below) that, as of the Effective Date, belong solely to me or belong to me jointly with others, and
that relate in any way to any of the Company’s proposed businesses, products or research and development, and which are
not assigned to the Company hereunder; or, if no such list is attached, I represent that there are no such Inventions at the time
of signing this Agreement.

 

(b)
Use or Incorporation of Inventions. If in the course of the Relationship, I use or incorporate into a product, process
or machine any Invention not covered by Section 4(d) of this Agreement in which I have an interest, I will promptly so inform
the Company. Whether or not I give such notice, I hereby irrevocably grant to the Company a nonexclusive, fully paid-up, royalty-free,
assumable, perpetual, worldwide license, with right to transfer and to sublicense, to practice and exploit such Invention and
to make, have made, copy, modify, make derivative works of, use, sell, import, and otherwise distribute under all applicable intellectual
properties without restriction of any kind.

 

(c)
Inventions. I understand that “Inventions” means discoveries, developments, concepts, designs,
ideas, know how, improvements, inventions, trade secrets and/or original works of authorship, whether or not patentable, copyrightable
or otherwise legally protectable. I understand this includes, but is not limited to, any new product, machine, article of manufacture,
biological material, method, procedure, process, technique, use, equipment, device, apparatus, system, compound, formulation,
composition of matter, design or configuration of any kind, or any improvement thereon. I understand that “Company Inventions”
means any and all Inventions that I may solely or jointly author, discover, develop, conceive, or reduce to practice during the
period of the Relationship, except as otherwise provided in Section 4(g) below.

 

(d)
Assignment of Company Inventions. I agree that I will promptly make full written disclosure to the Company, will
hold in trust for the sole right and benefit of the Company, and hereby assign to the Company, or its designee, all my right,
title and interest throughout the world in and to any and all Company Inventions. I further acknowledge that all Company Inventions
that are made by me (solely or jointly with others) within the scope of and during the period of the Relationship are “works
made for hire” (to the greatest extent permitted by applicable law) and are compensated by my salary. I hereby waive and
irrevocably quitclaim to the Company or its designee any and all claims, of any nature whatsoever, that I now have or may hereafter
have for infringement of any and all Company Inventions.

 

    	-2-

    	 

    

 

(e)
Maintenance of Records. I agree to keep and maintain adequate and current written records of all Company Inventions
made by me (solely or jointly with others) during the term of the Relationship. The records may be in the form of notes, sketches,
drawings, flow charts, electronic data or recordings, laboratory notebooks, or any other format. The records will be available
to and remain the sole property of the Company at all times. I agree not to remove such records from the Company’s place
of business except as expressly permitted by Company policy which may, from time to time, be revised at the sole election of the
Company for the purpose of furthering the Company’s business. I agree to deliver all such records (including any copies
thereof) to the Company at the time of termination of the Relationship as provided for in Sections 5 and 6.

 

(f)
Patent and Copyright Rights. I agree to assist the Company, or its designee, at its expense, in every proper way
to secure the Company’s, or its designee’s, rights in the Company Inventions and any copyrights, patents, trademarks,
mask work rights, moral rights, or other intellectual property rights relating thereto in any and all countries, including the
disclosure to the Company or its designee of all pertinent information and data with respect thereto, the execution of all applications,
specifications, oaths, assignments, recordations, and all other instruments which the Company or its designee shall deem necessary
in order to apply for, obtain, maintain and transfer such rights, or if not transferable, waive such rights, and in order to assign
and convey to the Company or its designee, and any successors, assigns and nominees the sole and exclusive right, title and interest
in and to such Company Inventions, and any copyrights, patents, mask work rights or other intellectual property rights relating
thereto. I further agree that my obligation to execute or cause to be executed, when it is in my power to do so, any such instrument
or papers shall continue during and at all times after the end of the Relationship and until the expiration of the last such intellectual
property right to expire in any country of the world. I hereby irrevocably designate and appoint the Company and its duly authorized
officers and agents as my agent and attorney-in-fact, to act for and in my behalf and stead to execute and file any such applications
and to do all other lawfully permitted acts to further the application for, prosecution, issuance, maintenance or transfer of
letters of patents, copyright, mask work and other registrations related to such Company Inventions. This power of attorney is
coupled with an interest and shall not be affected by my subsequent incapacity.

 

(g)
Exception to Assignments. I understand that the Company Inventions will not include, and the provisions of this
Agreement requiring assignment of inventions to the Company do not apply to, any invention which qualifies fully for exclusion
under the provisions of applicable state law or federal laws, if any. In order to assist in the determination of which inventions
qualify for such exclusion, I will advise the Company promptly in writing, during and after the term of the Relationship, of all
Inventions solely or jointly conceived or developed or reduced to practice by me during the period of the Relationship.

 

5.
Company Property; Returning Company Documents.
I acknowledge and agree that I have no expectation of privacy with respect to the Company’s telecommunications, networking
or information processing systems (including, without limitation, files, e-mail messages, and voice messages) and that my activity
and any files or messages on or using any of those systems may be monitored at any time without notice. I further agree that any
property situated on the Company’s premises and owned by the Company, including disks and other storage media, filing cabinets
or other work areas, is subject to inspection by Company personnel at any time with or without notice. I agree that, at the time
of termination of the Relationship, I will deliver to the Company (and will not keep in my possession, recreate or deliver to
anyone else) any and all devices, records, data, notes, reports, proposals, lists, correspondence, specifications, drawings, blueprints,
sketches, laboratory notebooks, materials, flow charts, equipment, other documents or property, or reproductions of any of the
aforementioned items developed by me pursuant to the Relationship or otherwise belonging to the Company, its successors or assigns.

 

    	-3-

    	 

    

 

6.
Termination Certification. In the
event of the termination of the Relationship, I agree to sign and deliver the “Termination Certification” attached
hereto as Exhibit B; however, my failure to sign and deliver the Termination Certification shall in no way diminish my
continuing obligations under this Agreement.

 

7.
Notice to Third Parties. I understand
and agree that the Company may, with or without prior notice to me and during or after the term of the Relationship, notify third
parties of my agreements and obligations under this Agreement.

 

8.
Solicitation of Employees, Consultants
and Other Parties. I agree that during the term of the Relationship, and for a period of twenty-four (24) months immediately
following the termination of the Relationship for any reason, whether with or without cause, I shall not either directly or indirectly
solicit, induce, recruit or encourage any of the Company’s employees or consultants to terminate their relationship with
the Company, or attempt to solicit, induce, recruit, encourage or take away employees or consultants of the Company, either for
myself or for any other person or entity. Further, during the Relationship and at any time following the termination of the Relationship
for any reason, whether with or without cause, I shall not use any Confidential Information of the Company to negatively influence
any of the Company’s clients or customers from purchasing Company products or services or to solicit or influence or attempt
to influence any client, customer or other person either directly or indirectly, to direct any purchase of products and/or services
to any person, firm, corporation, institution or other entity in competition with the business of the Company.

 

9.
At-Will Relationship. I understand
and acknowledge that, except as may be otherwise explicitly provided in a separate written agreement between the Company and me,
my Relationship with the Company is and shall continue to be at-will, as defined under applicable law, meaning that either I or
the Company may terminate the Relationship at any time for any reason or no reason, without further obligation or liability, other
than those provisions of this Agreement that explicitly survive the termination of the Relationship.

 

10.
Representations and Covenants.

 

(a)
Facilitation of Agreement. I agree to execute promptly, both during and after the end of the Relationship, any proper
oath, and to verify any proper document, required to carry out the terms of this Agreement, upon the Company’s written request
to do so.

 

(b)
No Conflicts. I represent that my performance of all the terms of this Agreement does not and will not breach any
agreement I have entered into, or will enter into, with any third party, including without limitation any agreement to keep in
confidence proprietary information or materials acquired by me in confidence or in trust prior to or during the Relationship.
I will not disclose to the Company or use any inventions, confidential or non-public proprietary information or material belonging
to any previous client, employer or any other party. I will not induce the Company to use any inventions, confidential or non-public
proprietary information, or material belonging to any previous client, employer or any other party. I acknowledge and agree that
I have listed on Exhibit A all agreements (e.g., non-competition agreements, non-solicitation of customers agreements, non-solicitation
of employees agreements, confidentiality agreements, inventions agreements, etc.), if any, with a current or former client, employer,
or any other person or entity, that may restrict my ability to accept employment with the Company or my ability to recruit or
engage customers or service providers on behalf of the Company, or otherwise relate to or restrict my ability to perform my duties
for the Company or any obligation I may have to the Company. I agree not to enter into any written or oral agreement that conflicts
with the provisions of this Agreement.

 

    	-4-

    	 

    

 

(c)
Voluntary Execution. I certify and acknowledge that I have carefully read all of the provisions of this Agreement,
that I understand and have voluntarily accepted such provisions, and that I will fully and faithfully comply with such provisions.

 

11.
General Provisions.

 

(a)
Governing Law. The validity, interpretation, construction and performance of this Agreement shall be governed by
the laws of the State of Delaware, without giving effect to the principles of conflict of laws.

 

(b)
Entire Agreement. This Agreement, along with the employment agreement between myself and the Company of even date
herewith (“Employment Agreement”) sets forth the entire agreement and understanding between the Company and me relating
to its subject matter and merges all prior discussions between us. No amendment to this Agreement will be effective unless in
writing signed by both parties to this Agreement. The Company shall not be deemed hereby to have waived any rights or remedies
it may have in law or equity, nor to have given any authorizations or waived any of its rights under this Agreement, unless, and
only to the extent, it does so by a specific writing signed by a duly authorized officer of the Company, it being understood that,
even if I am an officer of the Company, I will not have authority to give any such authorizations or waivers for the Company under
this Agreement without specific approval by the Board of Directors. Any subsequent change or changes in my duties, obligations,
rights or compensation will not affect the validity or scope of this Agreement.

 

(c)
Severability. If one or more of the provisions in this Agreement are deemed void or unenforceable to any extent
in any context, such provisions shall nevertheless be enforced to the fullest extent allowed by law in that and other contexts,
and the validity and force of the remainder of this Agreement shall not be affected.

 

(d)
Successors and Assigns. This Agreement will be binding upon my heirs, executors, administrators and other legal
representatives, and my successors and assigns, and will be for the benefit of the Company, its successors, and its assigns.

 

(e)
Remedies. I acknowledge and agree that violation of this Agreement by me may cause the Company irreparable harm,
and therefore agree that the Company will be entitled to seek extraordinary relief in court, including, but not limited to, temporary
restraining orders, preliminary injunctions and permanent injunctions without the necessity of posting a bond or other security
(or, where such a bond or security is required, I agree that a $1,000 bond will be adequate), in addition to and without prejudice
to any other rights or remedies that the Company may have for a breach of this Agreement.

 

(f)
ADVICE OF COUNSEL. I ACKNOWLEDGE THAT, IN EXECUTING THIS AGREEMENT, I HAVE HAD THE OPPORTUNITY TO SEEK THE ADVICE
OF INDEPENDENT LEGAL COUNSEL, AND I HAVE READ AND UNDERSTOOD ALL OF THE TERMS AND PROVISIONS OF THIS AGREEMENT. THIS AGREEMENT
SHALL NOT BE CONSTRUED AGAINST ANY PARTY BY REASON OF THE DRAFTING OR PREPARATION HEREOF.

 

    	-5-

    	 

    

 

The
parties have executed this Agreement on the respective dates set forth below, to be effective as of the Effective Date first above
written.

  

	COMPANY:	 	EMPLOYEE:
	 	 	 
	FORCE
    PROTECTION VIDEO EQUIPMENT CORPORATION	 	 	 
	 	 	 	 
	By:
    	 	 	 
	 	 	 	 
	 	 	 	 
	Name:
    	 	 
	 	 	(Signature)
	 	 	 
	Title:	 	 	 
	 	 	 	 
	 	 	 	 
	Date:
    	 	Date:	 
	 	 	 	 
	 	 	 	 
	Address:	 	Address:	 
	 	 	 	 

 

    	-6-

    	 

    

 

EXHIBIT
A

 

LIST
OF PRIOR INVENTIONS

AND ORIGINAL WORKS OF AUTHORSHIP

EXCLUDED UNDER SECTION 4(a)

 

	

    Title 	 	

    Date 	 	Identifying
    Number

    or Brief Description
	 	 	 	 	 

 

 

___
No inventions, improvements, or original works of authorship

 

___
Additional sheets attached

 

	Signature
    of Employee:	 	 
	 	 	 
	Print
    Name of Employee:	 	 

 

	Date:	 	 

 

    	 

    	 

    

 

EXHIBIT
B

 

TERMINATION
CERTIFICATION

 

This
is to certify that I do not have in my possession, nor have I failed to return, any devices, records, data, notes, reports, proposals,
lists, correspondence, specifications, drawings, blueprints, sketches, laboratory notebooks, flow charts, materials, equipment,
other documents or property, or copies or reproductions of any aforementioned items belonging to Force Protection Video Equipment
Corporation, a Florida corporation, its subsidiaries, affiliates, successors or assigns (collectively, the “Company”).

 

I
further certify that I have complied with all the terms of the Company’s Confidential Information and Invention Assignment
Agreement signed by me, including the reporting of any Inventions (as defined therein), conceived or made by me (solely or jointly
with others) covered by that agreement.

 

I
further agree that, in compliance with the Confidential Information and Invention Assignment Agreement, I will preserve as confidential
all trade secrets, confidential knowledge, data or other proprietary information relating to products, processes, know-how, designs,
formulas, developmental or experimental work, computer programs, data bases, other original works of authorship, customer lists,
business plans, financial information or other subject matter pertaining to any business of the Company or any of its employees,
clients, consultants or licensees.

 

I
further agree that for twenty-four (24) months from the date of this Certification, I shall not either directly or indirectly
solicit, induce, recruit or encourage any of the Company’s employees or consultants to terminate their relationship with
the Company, or attempt to solicit, induce, recruit, encourage or take away employees or consultants of the Company, either for
myself or for any other person or entity. Further, I shall not at any time use any Confidential Information of the Company to
negatively influence any of the Company’s clients or customers from purchasing Company products or services or to solicit
or influence or attempt to influence any client, customer or other person either directly or indirectly, to direct any purchase
of products and/or services to any person, firm, corporation, institution or other entity in competition with the business of
the Company.

 

	Date:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00321-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00321-of-00352.parquet"}]]